19 June 2012 08:19 [Source: ICIS news]
SINGAPORE (ICIS)--DSM has acquired all outstanding shares of US-based medical firm Kensey Nash at $38.50 (€30.40) per share, the Dutch specialty chemicals firm said on Tuesday.
The acquisition was made through a tender offer, which expired on 18 June, DSM said in a statement.
DSM expects to close the acquisition within “the next few days”, the company said.
Kensey Nash is largely focused on the manufacture of regenerative medicine utilising its proprietary collagen and synthetic polymer technology, it said.
($1 = €0.79)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections